Michael G. Kauffman
2018
In 2018, Michael G. Kauffman earned a total compensation of $2.3M as Chief Executive Officer at Karyopharm Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $268,625 |
---|---|
Option Awards | $1,444,660 |
Salary | $550,000 |
Other | $11,660 |
Total | $2,274,945 |
Kauffman received $1.4M in option awards, accounting for 64% of the total pay in 2018.
Kauffman also received $268.6K in non-equity incentive plan, $550K in salary and $11.7K in other compensation.
Rankings
In 2018, Michael G. Kauffman's compensation ranked 5,071st out of 14,244 executives tracked by ExecPay. In other words, Kauffman earned more than 64.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,071 | 64th |
Manufacturing | 1,908 | 67th |
Chemicals And Allied Products | 700 | 67th |
Drugs | 586 | 68th |
Pharmaceutical Preparations | 451 | 68th |
Kauffman's colleagues
We found four more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2018.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019